778 related articles for article (PubMed ID: 23403864)
1. Synthesis of mesoporous silica nanoparticles.
Wu SH; Mou CY; Lin HP
Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
4. Self-templating synthesis of hollow mesoporous silica and their applications in catalysis and drug delivery.
Fang X; Zhao X; Fang W; Chen C; Zheng N
Nanoscale; 2013 Mar; 5(6):2205-18. PubMed ID: 23400270
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional mesoporous silica nanoparticles as cooperative catalysts for the Tsuji-Trost reaction--tuning the reactivity of silica nanoparticles.
Dickschat AT; Behrends F; Surmiak S; Weiss M; Eckert H; Studer A
Chem Commun (Camb); 2013 Mar; 49(22):2195-7. PubMed ID: 23392252
[TBL] [Abstract][Full Text] [Related]
6. Antifogging and antireflection coatings fabricated by integrating solid and mesoporous silica nanoparticles without any post-treatments.
Xu L; He J
ACS Appl Mater Interfaces; 2012 Jun; 4(6):3293-9. PubMed ID: 22663342
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of colloidal silica nanoparticles of a tunable mesopore size and their application to the adsorption of biomolecules.
Fuertes AB; Valle-Vigón P; Sevilla M
J Colloid Interface Sci; 2010 Sep; 349(1):173-80. PubMed ID: 20570275
[TBL] [Abstract][Full Text] [Related]
9. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
Zhang J; Li X; Rosenholm JM; Gu HC
J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
[TBL] [Abstract][Full Text] [Related]
11. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Controllability of Mesoporous Silica Nanoparticles.
Yamamoto E; Kuroda K
Enzymes; 2018; 44():1-10. PubMed ID: 30360809
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of oxygen-deficient luminescent mesoporous silica nanoparticles for synchronous drug delivery and imaging.
He Q; Shi J; Cui X; Wei C; Zhang L; Wu W; Bu W; Chen H; Wu H
Chem Commun (Camb); 2011 Jul; 47(28):7947-9. PubMed ID: 21499640
[TBL] [Abstract][Full Text] [Related]
14. Stability of small mesoporous silica nanoparticles in biological media.
Lin YS; Abadeer N; Haynes CL
Chem Commun (Camb); 2011 Jan; 47(1):532-4. PubMed ID: 21082109
[TBL] [Abstract][Full Text] [Related]
15. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
16. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
17. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
18. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles in medicine--recent advances.
Mamaeva V; Sahlgren C; Lindén M
Adv Drug Deliv Rev; 2013 May; 65(5):689-702. PubMed ID: 22921598
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of mesoporous silica nanoparticles.
Asefa T; Tao Z
Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
